Coherent Market Insights published a business research report on Anal Cancer Market Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Anal Cancer Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Global Anal Cancer Market
Anal cancer is a very common type of disease and the main treatment options are surgery, chemotherapy and radiation therapy. The main treatments are discussed below. The most common type of surgery for anal cancer is chemoradiation, which is the most effective and doesn’t require a hospital stay. Depending on the type of cancer, you may also be offered a combination of treatments. The most common treatment for anal tumors is chemotherapy, which is an excellent option for many patients.
Anal cancer can be treated with several types of treatment options. Early detection is the key to survival, as the earlier the disease is detected, the better the chance of surviving. If it’s diagnosed early enough, it can be removed surgically. If it is not, however, there are some alternative treatments you can try. Surgery is the most common treatment for anal malignancies. Surgical removal of tumors is usually possible, though it can cause a severe infection.
𝐓𝐨 𝐠𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 @ https://www.coherentmarketinsights.com/insight/request-sample/4701
The global anal cancer market is estimated to be valued at US$ 810.4 million in 2021 and is expected to exhibit a CAGR of 6.3% over the forecast period (2021-2028).
Global Anal Cancer Market: Drivers
R&D of new drugs is expected to propel growth of the global anal cancer market over the forecast period. For example, Dana-Farber Cancer Institute, Massachusetts and Merck Sharp & Dohme Corp., in October 2016, initiated a phase II clinical study to assess the efficacy of Merck Sharp & Dohme Corp.’s Pembrolizumab, a monoclonal antibody drug, for treatment of advanced anal cancer.
Moreover, high prevalence of anal cancer is also expected to propel growth of the global anal cancer market over the forecast period. For example, the rate of new cases of anal cancer in the U.S. increased from 1.7 per 100,000 persons in 2008 to 1.8 per 100,000 persons in 2018, according to data published by the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program.
Global Anal Cancer Market: Restraints
Use of chemo drugs can lead to nausea, vomiting, loss of appetite, hair loss, diarrhea, mouth sores, and others. These side effects are expected to limit growth of the global anal cancer market.
𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/4701
Global Anal Cancer Market: Key Players
Major players operating in the global anal cancer market include, Amgen Inc., Atara Biotherapeutics Inc., Advaxis, Inc., Bristol-Myers Squibb Company, Bayer AG, BioMimetix JV, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Global BioPharma Inc., GlaxoSmithKline plc, ISA Pharmaceuticals, Johnson & Johnson Private Limited, Merck KGaA, Novartis AG, ORYX GmbH and Co. KG, Ono Pharmaceutical Co., Ltd., Onconova Therapeutics, LLC, Pfizer Inc., Spectrum Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Sanofi, and Takeda Pharmaceutical Company Limited.
Global Anal Cancer Market: Segmentation
By Drug Type
- Fluorouracil
- Cisplatin
- Carboplatin
- Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)
By Cancer Type:
- Carcinoma In-situ
- Squamous Cell Carcinoma
- Melanoma
- Adenocarcinoma
- Basal Cell Carcinoma
By Treatment Type:
- Chemotherapy
- Surgery
- Radiation Therapy
- Immunotherapy
By Distribution Channel:
- Hospitals & Clinics
- Research & Academic Institutes
- Long-term Care Centers
- Pharmacies
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/4701
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Cancer Type
- Market Snippet, By Treatment Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
- Market Dynamics
- Global Anal Cancer Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global Anal Cancer Market, By Drug Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Fluorouracil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Cisplatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Carboplatin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others (Others include Mitomycin, Oxaliplatin, Docetaxel, Leucovorin, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Anal Cancer Market, By Cancer Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Carcinoma In-situ
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Squamous Cell Carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Basal Cell Carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Anal Cancer Market, By Treatment Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Anal Cancer Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Long-term Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/anal-cancer-market-3964
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837